NRIX: Nurix Therapeutics, Inc. Stock

by  •  • Comments Off on NRIX: Nurix Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,385.56
Enterprise Value ($M) 1,275.56
Book Value ($M) 526.99
Book Value / Share 7.44
Price / Book 2.63
NCAV ($M) 477.04
NCAV / Share 6.73
Price / NCAV 2.90

Profitability (mra)
Return on Invested Capital (ROIC) -0.35
Return on Assets (ROA) -0.54
Return on Equity (ROE) -0.97

Liquidity (mrq)
Quick Ratio 6.46
Current Ratio 6.46

Balance Sheet (mrq) ($M)
Current Assets 619.39
Assets 669.34
Liabilities 142.35
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 54.55
Operating Income -213.03
Net Income -193.57

Cash Flow Statement (mra) ($M)
Cash From Operations -172.58
Cash from Investing -257.71
Cash from Financing 485.67

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
01-10 13G/A ARK Investment Management LLC
12-06 13G Fmr Llc
11-14 13G/A Wasatch Advisors Inc
11-14 13G/A Baker Bros. Advisors Lp 9.70 36.33
11-14 13G/A Redmile Group, LLC 9.90 38.80
11-14 13G/A Sands Arthur T 4.70 20.86
11-08 13G Wellington Management Group Llp 5.41 199.58
11-07 13G/A Morgan Stanley 2.70 -43.27
06-07 13G/A BlackRock, Inc. 10.20 30.11
02-14 13G/A Price T Rowe Associates Inc /md/ 4.90 -26.49
02-14 13G/A Deep Track Capital, LP 6.18 10.33
02-13 13G Vanguard Group Inc 5.36
2024-01-23 13G/A State Street Corp 1.90 -63.26

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-01-28 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-07-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-02-15 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-01-29 137,341 435,590 31.53
2025-01-28 55,512 311,983 17.79
2025-01-27 88,763 459,035 19.34
2025-01-24 71,825 396,865 18.10

(click for more detail)

Similar Companies
NEUP – Neuphoria Therapeutics Inc. NGNE – Neurogene Inc.
NKGN – NKGen Biotech, Inc. NTLA – Intellia Therapeutics, Inc.
OCS – Oculis Holding AG


Financial data and stock pages provided by
Fintel.io